This product is a human monoclonal antibody that is specific for Human DSG3. This antibody can be used in a variety of applications, such as ELISA, WB, IF.
Figure 1 Indirect IF staining of human skin with scFv mAbs demonstrates cell surface binding typical of PV.
Negative control is an scFv mAb against an irrelevant Ag. Positive control is a previously characterized anti-Dsg3 scFv mAb, (D31)2/2918. Scale bar, 20 μM.
Cho, M. J., Lo, A. S., Mao, X., Nagler, A. R., Ellebrecht, C. T., Mukherjee, E. M., ... & Payne, A. S. (2014). Shared VH1-46 gene usage by pemphigus vulgaris autoantibodies indicates common humoral immune responses among patients. Nature communications, 5(1), 1-11.
Figure 2 VH1-46 mAbs, but not VH5a mAb, induce suprabasal skin blisters in human skin organ culture. Scale bar, 100 μM.
Cho, M. J., Lo, A. S., Mao, X., Nagler, A. R., Ellebrecht, C. T., Mukherjee, E. M., ... & Payne, A. S. (2014). Shared VH1-46 gene usage by pemphigus vulgaris autoantibodies indicates common humoral immune responses among patients. Nature communications, 5(1), 1-11.
Figure 3 GL LC/HC recombinant Abs were generated for those mAbs that were insoluble in their fully GL state.
(a) F706 germline-reverted (GL) and (b) F779GL Abs do not bind Dsg3. (c) 3.2 GL Ab binds Dsg3 by ELISA with reduced affinity. (d) PVE4-8 GL and (e) 4.2 GL Abs retain binding to Dsg3 by ELISA. Black/grey hatched lines indicate GL1/2 Abs, respectively. (f-j) Germline-reverted non-VH1-46 mAbs do not demonstrate binding to Dsg3 by ELISA.
Cho, M. J., Lo, A. S., Mao, X., Nagler, A. R., Ellebrecht, C. T., Mukherjee, E. M., ... & Payne, A. S. (2014). Shared VH1-46 gene usage by pemphigus vulgaris autoantibodies indicates common humoral immune responses among patients. Nature communications, 5(1), 1-11.
Figure 4 Binding of F706GL2+D/E to native human skin tissue was confirmed by indirect IF.
Cho, M. J., Lo, A. S., Mao, X., Nagler, A. R., Ellebrecht, C. T., Mukherjee, E. M., ... & Payne, A. S. (2014). Shared VH1-46 gene usage by pemphigus vulgaris autoantibodies indicates common humoral immune responses among patients. Nature communications, 5(1), 1-11.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
DrMAB-172 | Human Anti-DSG3 Recombinant Antibody (clone PVA3) | ELISA | Human IgG |
FAMAB-0203-CN | Human Anti-DSG3 Recombinant Antibody (clone (D3)1b/3a) | ELISA, IF, IB | Human IgG |
FAMAB-0205-CN | Human Anti-DSG3 Recombinant Antibody (clone (D3)3a/9) | ELISA, IF, IB | Human IgG |
FAMAB-1111CQ | Human Anti-DSG3 Recombinant Antibody (clone PVA224) | IF, ELISA, IHC | Human IgG1 |
FAMAB-1113CQ | Mouse Anti-DSG3 Recombinant Antibody (clone PVB28) | IF, ELISA, IHC | Mouse IgG1 |
There are currently no Customer reviews or questions for FAMAB-0518WJ. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.